The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.

Toll-like receptors (TLRs) represent the main class of pattern-recognition receptors involved in sensing pathogenic microorganisms. The aim of the present study was to assess the role of TLR4 in the defense against Candida albicans infection. The outgrowth of C. albicans was 10-fold higher in TLR4-defective C3H/HeJ mice, compared with that in control C3H/HeN mice (P<.05). Production of tumor necrosis factor (TNF) and interleukin (IL)-1alpha and IL-1beta by mouse macrophages in response to C. albicans stimulation was not affected by TLR4, and the candidacidal capacities of the neutrophils and macrophages of C3H/HeJ mice were normal. In contrast, production of the CXC chemokines KC and macrophage inhibitory protein-2 was 40%-60% lower by the macrophages of C3H/HeJ mice (P<.05), which resulted in a 40% decrease in neutrophil recruitment to the site of infection. Candida-induced TNF and IL-1beta production by human peripheral blood mononuclear cells was significantly inhibited by blocking anti-TLR2 antibodies in vitro. In conclusion, TLR4-defective C3H/HeJ mice are more susceptible to C. albicans infection, and this is associated with impaired chemokine expression and neutrophil recruitment.

[1]  J. Belisle,et al.  Different Toll‐like receptor agonists induce distinct macrophage responses , 2001, Journal of leukocyte biology.

[2]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[3]  A. Aasen,et al.  Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes by Aspergillus fumigatus Hyphae , 2001, Infection and Immunity.

[4]  D. Golenbock,et al.  Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-α Release in Response to Cryptococcus neoformans Polysaccharide Capsule1 , 2001, The Journal of Immunology.

[5]  C. Svanborg,et al.  Escherichia coli P fimbriae utilize the Toll‐like receptor 4 pathway for cell activation , 2001, Molecular microbiology.

[6]  D. Golenbock,et al.  Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2 , 2001, Infection and Immunity.

[7]  D. Golenbock,et al.  Extolling the diversity of bacterial endotoxins , 2001, Nature Immunology.

[8]  M. J. Cody,et al.  Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages , 2001, Infection and Immunity.

[9]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[10]  S. Akira,et al.  CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.

[11]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[12]  Y. Ohmori,et al.  Interleukin-1-mediated Stabilization of Mouse KC mRNA Depends on Sequences in both 5′- and 3′-Untranslated Regions* , 2000, The Journal of Biological Chemistry.

[13]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[14]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[15]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[16]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[17]  J. Verhoef,et al.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). , 1999, Diagnostic microbiology and infectious disease.

[18]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[19]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[21]  Ajay K. Singh,et al.  Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism , 1999, Clinical Diagnostic Laboratory Immunology.

[22]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[23]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[24]  F. Fang.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[25]  F. Fang.  Mechanisms of nitric oxide-related antimicrobial activity , 1997 .

[26]  A. Vázquez-Torres,et al.  Macrophages in resistance to candidiasis. , 1997, Microbiology and molecular biology reviews : MMBR.

[27]  T. Klein,et al.  Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages , 1997, Infection and immunity.

[28]  B. Lemaître,et al.  The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.

[29]  C. Forsyth,et al.  Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. , 1996, Cellular immunology.

[30]  M. Netea,et al.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. , 1996, The Journal of clinical investigation.

[31]  S. Van Uum,et al.  Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. , 1995, Journal of applied physiology.

[32]  F. Blecha,et al.  CD14 and other recognition molecules for lipopolysaccharide: a review. , 1995, Immunopharmacology.

[33]  B. Kullberg,et al.  Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. , 1993, The Journal of infectious diseases.

[34]  R. Johnston,et al.  Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. , 1991, Journal of immunology.

[35]  B. Kullberg,et al.  Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1 , 1990, Infection and immunity.

[36]  C. Nathan,et al.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.

[37]  R. Lehrer,et al.  Interaction of Candida albicans with Human Leukocytes and Serum , 1969, Journal of bacteriology.

[38]  S. Dower,et al.  A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. , 2001, The Journal of infectious diseases.

[39]  S. Shoham,et al.  Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-a Release in Response to Cryptococcus neoformans Polysaccharide Capsule , 2001 .

[40]  Keith A. Joiner,et al.  Perspectives Series: Host/Pathogen Interactions , 1997 .

[41]  C. Dahlgren,et al.  Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. , 1996, Free radical biology & medicine.